Integrative multi-omics identifies MSR1 as a programmed cell death and extracellular matrix hub gene in osteoarthritis with hesperidin targeting potential - Summary - MDSpire

Integrative multi-omics identifies MSR1 as a programmed cell death and extracellular matrix hub gene in osteoarthritis with hesperidin targeting potential

  • By

  • Bao, Jinquan

  • Wu, Lingling

  • Zhao, Wenqiang

  • Li, Bo

  • Li, Zilong

  • Bai, Zhigang

  • Ma, Penglei

  • Gao, Bo

  • Qiao, Chenggang

  • March 30, 2026

  • 0 min

Share

Objective:

To identify a key programmed cell death (PCD)/extracellular matrix (ECM)-related gene involved in osteoarthritis (OA) pathogenesis through multi-omics analysis.

Key Findings:
  • MSR1 was identified as a key candidate gene with higher expression in OA samples compared to healthy samples.
  • MSR1 expression correlated positively with immune populations and microenvironment scores.
  • Hesperidin was identified as a high-affinity MSR1-binding compound with stable interactions.
Interpretation:

MSR1 plays a significant role in OA pathogenesis through immune modulation and may serve as a therapeutic target, with hesperidin showing potential as a treatment.

Limitations:
  • The study primarily relies on bioinformatics and in vitro models, which may not fully replicate in vivo conditions.
  • Further validation in clinical settings is required to confirm findings.
Conclusion:

MSR1 is a central regulator in OA pathogenesis, and hesperidin may offer a novel therapeutic approach, providing insights into OA mechanisms and drug discovery.

Original Source(s)

Related Content